Is Dexmedetomidine the Key for Reducing Acute Kidney Injury After Cardiac Surgery?

J Cardiothorac Vasc Anesth. 2020 Mar;34(3):614-615. doi: 10.1053/j.jvca.2019.10.058. Epub 2019 Nov 8.

Authors

Patrick M Wieruszewski¹, Erica D Wittwer²

Affiliations

¹ Department of Pharmacy, Mayo Clinic, Rochester, MN; Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Group, Mayo Clinic, Rochester, MN.
² Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Group, Mayo Clinic, Rochester, MN; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.

PMID: 31791854
DOI: 10.1053/j.jvca.2019.10.058

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Kidney Injury*
Cardiac Surgical Procedures*
Dexmedetomidine*
Humans
Randomized Controlled Trials as Topic

Substances

Dexmedetomidine